Здоровье
The US FDA has suspended trials of Kezar Life Sciences’ drug for the treatment of lupus
The US Food and Drug Administration has banned clinical trials of the drug Kezar Life Sciences, said the company, which is testing an experimental drug
A patient who survived a rare rapid ageing disease, progeria, has died at the age of 28
Sammy Basso, who was the longest-living person to suffer from the rare genetic disease progeria, has died at the age of 28, the Italian Progeria
Novo Nordisk to invest $158 million in insulin plant in Brazil
Danish drugmaker Novo Nordisk will invest $158.2 million to modernise a plant in Brazil responsible for pumping a quarter of its global insulin production. The
Congo launches its first mpox vaccination campaign
Congolese health authorities launched their first mpox vaccination campaign, a key step in efforts to contain an outbreak that has spread from its epicentre in
Chilean scientists develop reversible vaccine to spay/neuter dogs
Leonardo Sáenz, a veterinarian and professor at the University of Chile, developed an immunocastration vaccine called Egalitte that works by blocking the hormone in charge
US FDA approves GE HealthCare’s diagnostic drug for the treatment of heart disease
The US Food and Drug Administration has approved a GE HealthCare diagnostic drug for use in the detection of coronary heart disease. Flyrcado, a radioactive
Sanofi-Regeneron’s Dupixent drug has received FDA approval for ‘smoker’s lungs’
The US Food and Drug Administration approved Sanofi and Regeneron. The companies said the blocker drug Dupixent is intended for patients with chronic lung disease,
Grifols plans to invest $402 million in new industrial centre
Spanish drug maker Grifols plans to invest 360 million euros ($401.98 million) to build a new industrial plant in Barcelona for its engineering department, El
Six people have died from the Marburg virus in Rwanda
Six deaths and 20 cases of Marburg disease have been confirmed in Rwanda since the beginning of the epidemic, the country’s Health Minister Sabine Nsanzimana
US FDA approves GE HealthCare’s diagnostic drug for the treatment of heart disease
The US Food and Drug Administration has approved a GE HealthCare diagnostic drug for use in detecting coronary heart disease, the company said on Friday.